| High Risk Neuroblastoma investigated in trials for …INVESTIGATED_IN_TRIALSderived16 of 16show fewer |
|---|
| → investigated in trials for | Cyclophosphamidesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | High Risk Neuroblastoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | High Risk Neuroblastoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dinutuximabmonoclonal_antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | High Risk Neuroblastoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | High Risk Neuroblastoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | High Risk Neuroblastoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | High Risk Neuroblastoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | High Risk Neuroblastoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | High Risk Neuroblastoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | High Risk Neuroblastoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | High Risk Neuroblastoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | High Risk Neuroblastoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dinutuximab Betamonoclonal_antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |